Navigating the Challenge of Tuberculosis Drug Resistance: Unveiling Intrinsic and Acquired Pathways to Overcome the Threat

References (56)

1. 1 Global tuberculosis report (2014)
2. 2 Distinguishing between resistance, tolerance and persistence to antibiotic treatment [DOI]
3. 3 The spectrum of latent tuberculosis: rethinking the biology and intervention strategies [DOI]
4. 4 Ancient Origin and Gene Mosaicism of the Progenitor of Mycobacterium tuberculosis [DOI]
5. 5 High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography [DOI]
6. 6 Tuberculosis: Latency and Reactivation [DOI]
7. 7 Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection [DOI]
8. 8 Efflux pump inhibitors for bacterial pathogens [DOI]
9. 9 Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go? [DOI]
10. 10 A Novel In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen [DOI]
11. 11 Drug Resistance Mechanisms in Mycobacterium tuberculosis [DOI]
12. 12 WHO global progress report on tuberculosis elimination [DOI]
13. 13 Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance [DOI]
14. 14 Mycobacterium tuberculosis invades and replicates within type II alveolar cells [DOI]
15. 15 Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis [DOI]
16. 16 Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages [DOI]
17. 17 Initiation and regulation of T-cell responses in tuberculosis [DOI]
18. 18 THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION. [DOI]
19. 19 Bacterial Enzymes and Antibiotic Resistance [DOI]
20. 20 The equilibria that allow bacterial persistence in human hosts [DOI]
21. 21 Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis [DOI]
22. 22 Latent tuberculosis: what the host “sees”? [DOI]
23. 23 Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates [DOI]
24. 24 The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis [DOI]
25. 25 Strategies to Overcome the Action of Aminoglycoside-Modifying Enzymes for Treating Resistant Bacterial Infections [DOI]
26. 26 The Mycobacterial Transcriptional Regulator whiB7 Gene Links Redox Homeostasis and Intrinsic Antibiotic Resistance [DOI]
27. 27 The mycobacterial antibiotic resistance determinant WhiB7 acts as a transcriptional activator by binding the primary sigma factor SigA (RpoV) [DOI]
28. 28 Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria [DOI]
29. 29 Triacylglycerols: Fuelling the Hibernating Mycobacterium tuberculosis [DOI]
30. 30 Metabolic Versatility of Mycobacterium tuberculosis during Infection and Dormancy [DOI]
31. 31 Antibiotics and resistance: the two-sided coin of the mycobacterial cell wall [DOI]
32. 32 Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis [DOI]
33. 33 Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action [DOI]
34. 34 Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages.
35. 35 Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication [DOI]
36. 36 Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates [DOI]
37. 37 Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis [DOI]
38. 38 Tuberculosis control in vulnerable groups [DOI]
39. 39 Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance [DOI]
40. 40 Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates [DOI]
41. 41 The Expression of ABC Efflux Pump, Rv1217c–Rv1218c, and Its Association with Multidrug Resistance of Mycobacterium tuberculosis in China [DOI]
42. 42 Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis [DOI]
43. 43 Integrated Modeling of Gene Regulatory and Metabolic Networks in Mycobacterium tuberculosis [DOI]
44. 44 Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs [DOI]
45. 45 Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner [DOI]
46. 46 Investigation of the Rv3065, Rv2942, Rv1258c, Rv1410c, and Rv2459 efflux pump genes expression among multidrug-resistant Mycobacterium tuberculosis clinical isolates [DOI]
47. 47 Rekindling old controversy on elusive lair of latent tuberculosis [DOI]
48. 48 Mutation in atpE and Rv0678 genes associated with bedaquline resistance among drug-resistant tuberculosis patients: A pilot study from a high-burden setting in Northern India [DOI]
49. 49 The Mycobacterial Cell Wall—Peptidoglycan and Arabinogalactan [DOI]
50. 50 The evolving biology of Mycobacterium tuberculosis drug resistance [DOI]
51. 51 Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis [DOI]
52. 52 Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India [DOI]
53. 53 Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates [DOI]
54. 54 How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery [DOI]
55. 55 Early phase of effective treatment induces distinct transcriptional changes in Mycobacterium tuberculosis expelled by pulmonary tuberculosis patients [DOI]
56. 56 Identification of S315T mutation in katG gene using probe-free exclusive mismatch primers for a rapid diagnosis of isoniazid-resistant Mycobacterium tuberculosis by real-time loop-mediated isothermal amplification [DOI]

Cited by 1

1 citation reported by external sources — individual citing-article records aren't available to list yet.

Related research

• Outcome of Childhood Tuberculosis at a Specialist Hospital in Gusau, Nigeria — shares topic coverage
• Weight Gain as Tuberculosis Treatment Regimen Progresses in Patients Receiving Antituberculosis Therapy — shares topic coverage
• Socio-Demographic and Nutritional Status Correlates in Pulmonary Tuberculosis Patients in Calabar, Nigeria — shares topic coverage
• Diagnostic Accuracy of Ziehl-Neelsen Smear Microscopy in Comparison with GeneXpert in Pulmonary Tuberculosis: A Multi-Center Study in Kandahar Province, Afghanistan — shares topic coverage
• A Short History of the BCG Vaccine — shares topic coverage